Pharma & Healthcare
Global Recombinant FVIII Market Insights, Forecast to 2030
- Nov 02, 24
- ID: 653300
- Pages: 95
- Figures: 115
- Views: 1
Recombinant FVIII
The global Recombinant FVIII market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Covers:
This report presents an overview of global market for Recombinant FVIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant FVIII, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant FVIII, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant FVIII sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant FVIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant FVIII sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Comirnaty
Novo Nordisk
Green Cross
Sinocelltech
Segment by Type
250 IU/bottle
500 IU/bottle
1000 IU/bottle
2000 IU/bottle
Segment by Application
Teenagers
Adults
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant FVIII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant FVIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant FVIII sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
The global Recombinant FVIII market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Covers:
This report presents an overview of global market for Recombinant FVIII, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant FVIII, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Recombinant FVIII, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant FVIII sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant FVIII market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Recombinant FVIII sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Comirnaty
Novo Nordisk
Green Cross
Sinocelltech
Segment by Type
250 IU/bottle
500 IU/bottle
1000 IU/bottle
2000 IU/bottle
Segment by Application
Teenagers
Adults
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Recombinant FVIII in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Recombinant FVIII manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant FVIII sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Recombinant FVIII Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant FVIII Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 250 IU/bottle
1.2.3 500 IU/bottle
1.2.4 1000 IU/bottle
1.2.5 2000 IU/bottle
1.3 Market by Application
1.3.1 Global Recombinant FVIII Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Teenagers
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant FVIII Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant FVIII Revenue by Region
2.2.1 Global Recombinant FVIII Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant FVIII Revenue by Region (2019-2024)
2.2.3 Global Recombinant FVIII Revenue by Region (2025-2030)
2.2.4 Global Recombinant FVIII Revenue Market Share by Region (2019-2030)
2.3 Global Recombinant FVIII Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant FVIII Sales by Region
2.4.1 Global Recombinant FVIII Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant FVIII Sales by Region (2019-2024)
2.4.3 Global Recombinant FVIII Sales by Region (2025-2030)
2.4.4 Global Recombinant FVIII Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant FVIII Sales by Manufacturers
3.1.1 Global Recombinant FVIII Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant FVIII Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant FVIII in 2023
3.2 Global Recombinant FVIII Revenue by Manufacturers
3.2.1 Global Recombinant FVIII Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant FVIII Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant FVIII Revenue in 2023
3.3 Global Key Players of Recombinant FVIII, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant FVIII Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant FVIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant FVIII, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant FVIII, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant FVIII, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant FVIII Sales by Type
4.1.1 Global Recombinant FVIII Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant FVIII Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant FVIII Sales Market Share by Type (2019-2030)
4.2 Global Recombinant FVIII Revenue by Type
4.2.1 Global Recombinant FVIII Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant FVIII Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant FVIII Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant FVIII Price by Type
4.3.1 Global Recombinant FVIII Price by Type (2019-2024)
4.3.2 Global Recombinant FVIII Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Recombinant FVIII Sales by Application
5.1.1 Global Recombinant FVIII Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant FVIII Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant FVIII Sales Market Share by Application (2019-2030)
5.2 Global Recombinant FVIII Revenue by Application
5.2.1 Global Recombinant FVIII Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant FVIII Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant FVIII Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant FVIII Price by Application
5.3.1 Global Recombinant FVIII Price by Application (2019-2024)
5.3.2 Global Recombinant FVIII Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant FVIII Market Size by Type
6.1.1 US & Canada Recombinant FVIII Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant FVIII Revenue by Type (2019-2030)
6.2 US & Canada Recombinant FVIII Market Size by Application
6.2.1 US & Canada Recombinant FVIII Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant FVIII Revenue by Application (2019-2030)
6.3 US & Canada Recombinant FVIII Market Size by Country
6.3.1 US & Canada Recombinant FVIII Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant FVIII Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant FVIII Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant FVIII Market Size by Type
7.1.1 Europe Recombinant FVIII Sales by Type (2019-2030)
7.1.2 Europe Recombinant FVIII Revenue by Type (2019-2030)
7.2 Europe Recombinant FVIII Market Size by Application
7.2.1 Europe Recombinant FVIII Sales by Application (2019-2030)
7.2.2 Europe Recombinant FVIII Revenue by Application (2019-2030)
7.3 Europe Recombinant FVIII Market Size by Country
7.3.1 Europe Recombinant FVIII Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant FVIII Sales by Country (2019-2030)
7.3.3 Europe Recombinant FVIII Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant FVIII Market Size
8.1.1 China Recombinant FVIII Sales (2019-2030)
8.1.2 China Recombinant FVIII Revenue (2019-2030)
8.2 China Recombinant FVIII Market Size by Application
8.2.1 China Recombinant FVIII Sales by Application (2019-2030)
8.2.2 China Recombinant FVIII Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant FVIII Market Size by Type
9.1.1 Asia Recombinant FVIII Sales by Type (2019-2030)
9.1.2 Asia Recombinant FVIII Revenue by Type (2019-2030)
9.2 Asia Recombinant FVIII Market Size by Application
9.2.1 Asia Recombinant FVIII Sales by Application (2019-2030)
9.2.2 Asia Recombinant FVIII Revenue by Application (2019-2030)
9.3 Asia Recombinant FVIII Sales by Region
9.3.1 Asia Recombinant FVIII Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant FVIII Revenue by Region (2019-2030)
9.3.3 Asia Recombinant FVIII Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant FVIII Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant FVIII Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant FVIII Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant FVIII Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant FVIII Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant FVIII Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant FVIII Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant FVIII Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant FVIII Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant FVIII Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Overview
11.1.3 Bayer Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bayer Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Overview
11.2.3 Baxter Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Baxter Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 Comirnaty
11.3.1 Comirnaty Company Information
11.3.2 Comirnaty Overview
11.3.3 Comirnaty Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Comirnaty Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Comirnaty Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novo Nordisk Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novo Nordisk Recent Developments
11.5 Green Cross
11.5.1 Green Cross Company Information
11.5.2 Green Cross Overview
11.5.3 Green Cross Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Green Cross Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Green Cross Recent Developments
11.6 Sinocelltech
11.6.1 Sinocelltech Company Information
11.6.2 Sinocelltech Overview
11.6.3 Sinocelltech Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Sinocelltech Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sinocelltech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant FVIII Industry Chain Analysis
12.2 Recombinant FVIII Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant FVIII Production Mode & Process
12.4 Recombinant FVIII Sales and Marketing
12.4.1 Recombinant FVIII Sales Channels
12.4.2 Recombinant FVIII Distributors
12.5 Recombinant FVIII Customers
13 Market Dynamics
13.1 Recombinant FVIII Industry Trends
13.2 Recombinant FVIII Market Drivers
13.3 Recombinant FVIII Market Challenges
13.4 Recombinant FVIII Market Restraints
14 Key Findings in The Global Recombinant FVIII Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Recombinant FVIII Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant FVIII Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 250 IU/bottle
1.2.3 500 IU/bottle
1.2.4 1000 IU/bottle
1.2.5 2000 IU/bottle
1.3 Market by Application
1.3.1 Global Recombinant FVIII Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Teenagers
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Recombinant FVIII Sales Estimates and Forecasts 2019-2030
2.2 Global Recombinant FVIII Revenue by Region
2.2.1 Global Recombinant FVIII Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Recombinant FVIII Revenue by Region (2019-2024)
2.2.3 Global Recombinant FVIII Revenue by Region (2025-2030)
2.2.4 Global Recombinant FVIII Revenue Market Share by Region (2019-2030)
2.3 Global Recombinant FVIII Sales Estimates and Forecasts 2019-2030
2.4 Global Recombinant FVIII Sales by Region
2.4.1 Global Recombinant FVIII Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Recombinant FVIII Sales by Region (2019-2024)
2.4.3 Global Recombinant FVIII Sales by Region (2025-2030)
2.4.4 Global Recombinant FVIII Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Recombinant FVIII Sales by Manufacturers
3.1.1 Global Recombinant FVIII Sales by Manufacturers (2019-2024)
3.1.2 Global Recombinant FVIII Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Recombinant FVIII in 2023
3.2 Global Recombinant FVIII Revenue by Manufacturers
3.2.1 Global Recombinant FVIII Revenue by Manufacturers (2019-2024)
3.2.2 Global Recombinant FVIII Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Recombinant FVIII Revenue in 2023
3.3 Global Key Players of Recombinant FVIII, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Recombinant FVIII Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Recombinant FVIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Recombinant FVIII, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Recombinant FVIII, Product Offered and Application
3.8 Global Key Manufacturers of Recombinant FVIII, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Recombinant FVIII Sales by Type
4.1.1 Global Recombinant FVIII Historical Sales by Type (2019-2024)
4.1.2 Global Recombinant FVIII Forecasted Sales by Type (2025-2030)
4.1.3 Global Recombinant FVIII Sales Market Share by Type (2019-2030)
4.2 Global Recombinant FVIII Revenue by Type
4.2.1 Global Recombinant FVIII Historical Revenue by Type (2019-2024)
4.2.2 Global Recombinant FVIII Forecasted Revenue by Type (2025-2030)
4.2.3 Global Recombinant FVIII Revenue Market Share by Type (2019-2030)
4.3 Global Recombinant FVIII Price by Type
4.3.1 Global Recombinant FVIII Price by Type (2019-2024)
4.3.2 Global Recombinant FVIII Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Recombinant FVIII Sales by Application
5.1.1 Global Recombinant FVIII Historical Sales by Application (2019-2024)
5.1.2 Global Recombinant FVIII Forecasted Sales by Application (2025-2030)
5.1.3 Global Recombinant FVIII Sales Market Share by Application (2019-2030)
5.2 Global Recombinant FVIII Revenue by Application
5.2.1 Global Recombinant FVIII Historical Revenue by Application (2019-2024)
5.2.2 Global Recombinant FVIII Forecasted Revenue by Application (2025-2030)
5.2.3 Global Recombinant FVIII Revenue Market Share by Application (2019-2030)
5.3 Global Recombinant FVIII Price by Application
5.3.1 Global Recombinant FVIII Price by Application (2019-2024)
5.3.2 Global Recombinant FVIII Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Recombinant FVIII Market Size by Type
6.1.1 US & Canada Recombinant FVIII Sales by Type (2019-2030)
6.1.2 US & Canada Recombinant FVIII Revenue by Type (2019-2030)
6.2 US & Canada Recombinant FVIII Market Size by Application
6.2.1 US & Canada Recombinant FVIII Sales by Application (2019-2030)
6.2.2 US & Canada Recombinant FVIII Revenue by Application (2019-2030)
6.3 US & Canada Recombinant FVIII Market Size by Country
6.3.1 US & Canada Recombinant FVIII Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Recombinant FVIII Sales by Country (2019-2030)
6.3.3 US & Canada Recombinant FVIII Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Recombinant FVIII Market Size by Type
7.1.1 Europe Recombinant FVIII Sales by Type (2019-2030)
7.1.2 Europe Recombinant FVIII Revenue by Type (2019-2030)
7.2 Europe Recombinant FVIII Market Size by Application
7.2.1 Europe Recombinant FVIII Sales by Application (2019-2030)
7.2.2 Europe Recombinant FVIII Revenue by Application (2019-2030)
7.3 Europe Recombinant FVIII Market Size by Country
7.3.1 Europe Recombinant FVIII Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Recombinant FVIII Sales by Country (2019-2030)
7.3.3 Europe Recombinant FVIII Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Recombinant FVIII Market Size
8.1.1 China Recombinant FVIII Sales (2019-2030)
8.1.2 China Recombinant FVIII Revenue (2019-2030)
8.2 China Recombinant FVIII Market Size by Application
8.2.1 China Recombinant FVIII Sales by Application (2019-2030)
8.2.2 China Recombinant FVIII Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant FVIII Market Size by Type
9.1.1 Asia Recombinant FVIII Sales by Type (2019-2030)
9.1.2 Asia Recombinant FVIII Revenue by Type (2019-2030)
9.2 Asia Recombinant FVIII Market Size by Application
9.2.1 Asia Recombinant FVIII Sales by Application (2019-2030)
9.2.2 Asia Recombinant FVIII Revenue by Application (2019-2030)
9.3 Asia Recombinant FVIII Sales by Region
9.3.1 Asia Recombinant FVIII Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Recombinant FVIII Revenue by Region (2019-2030)
9.3.3 Asia Recombinant FVIII Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Recombinant FVIII Market Size by Type
10.1.1 Middle East, Africa and Latin America Recombinant FVIII Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Recombinant FVIII Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Recombinant FVIII Market Size by Application
10.2.1 Middle East, Africa and Latin America Recombinant FVIII Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Recombinant FVIII Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Recombinant FVIII Sales by Country
10.3.1 Middle East, Africa and Latin America Recombinant FVIII Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Recombinant FVIII Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Recombinant FVIII Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Company Information
11.1.2 Bayer Overview
11.1.3 Bayer Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bayer Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Baxter
11.2.1 Baxter Company Information
11.2.2 Baxter Overview
11.2.3 Baxter Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Baxter Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Baxter Recent Developments
11.3 Comirnaty
11.3.1 Comirnaty Company Information
11.3.2 Comirnaty Overview
11.3.3 Comirnaty Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Comirnaty Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Comirnaty Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Information
11.4.2 Novo Nordisk Overview
11.4.3 Novo Nordisk Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Novo Nordisk Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novo Nordisk Recent Developments
11.5 Green Cross
11.5.1 Green Cross Company Information
11.5.2 Green Cross Overview
11.5.3 Green Cross Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Green Cross Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Green Cross Recent Developments
11.6 Sinocelltech
11.6.1 Sinocelltech Company Information
11.6.2 Sinocelltech Overview
11.6.3 Sinocelltech Recombinant FVIII Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Sinocelltech Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sinocelltech Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Recombinant FVIII Industry Chain Analysis
12.2 Recombinant FVIII Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Recombinant FVIII Production Mode & Process
12.4 Recombinant FVIII Sales and Marketing
12.4.1 Recombinant FVIII Sales Channels
12.4.2 Recombinant FVIII Distributors
12.5 Recombinant FVIII Customers
13 Market Dynamics
13.1 Recombinant FVIII Industry Trends
13.2 Recombinant FVIII Market Drivers
13.3 Recombinant FVIII Market Challenges
13.4 Recombinant FVIII Market Restraints
14 Key Findings in The Global Recombinant FVIII Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Recombinant FVIII Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 250 IU/bottle
Table 3. Major Manufacturers of 500 IU/bottle
Table 4. Major Manufacturers of 1000 IU/bottle
Table 5. Major Manufacturers of 2000 IU/bottle
Table 6. Global Recombinant FVIII Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Recombinant FVIII Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Recombinant FVIII Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Recombinant FVIII Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Recombinant FVIII Revenue Market Share by Region (2019-2024)
Table 11. Global Recombinant FVIII Revenue Market Share by Region (2025-2030)
Table 12. Global Recombinant FVIII Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Recombinant FVIII Sales by Region (2019-2024) & (K Units)
Table 14. Global Recombinant FVIII Sales by Region (2025-2030) & (K Units)
Table 15. Global Recombinant FVIII Sales Market Share by Region (2019-2024)
Table 16. Global Recombinant FVIII Sales Market Share by Region (2025-2030)
Table 17. Global Recombinant FVIII Sales by Manufacturers (2019-2024) & (K Units)
Table 18. Global Recombinant FVIII Sales Share by Manufacturers (2019-2024)
Table 19. Global Recombinant FVIII Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Recombinant FVIII Revenue Share by Manufacturers (2019-2024)
Table 21. Global Key Players of Recombinant FVIII, Industry Ranking, 2022 VS 2023 VS 2024
Table 22. Recombinant FVIII Price by Manufacturers 2019-2024 (USD/Unit)
Table 23. Global Recombinant FVIII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Recombinant FVIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant FVIII as of 2023)
Table 25. Global Key Manufacturers of Recombinant FVIII, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Recombinant FVIII, Product Offered and Application
Table 27. Global Key Manufacturers of Recombinant FVIII, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 30. Global Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 31. Global Recombinant FVIII Sales Share by Type (2019-2024)
Table 32. Global Recombinant FVIII Sales Share by Type (2025-2030)
Table 33. Global Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Recombinant FVIII Revenue Share by Type (2019-2024)
Table 36. Global Recombinant FVIII Revenue Share by Type (2025-2030)
Table 37. Recombinant FVIII Price by Type (2019-2024) & (USD/Unit)
Table 38. Global Recombinant FVIII Price Forecast by Type (2025-2030) & (USD/Unit)
Table 39. Global Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 40. Global Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 41. Global Recombinant FVIII Sales Share by Application (2019-2024)
Table 42. Global Recombinant FVIII Sales Share by Application (2025-2030)
Table 43. Global Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Recombinant FVIII Revenue Share by Application (2019-2024)
Table 46. Global Recombinant FVIII Revenue Share by Application (2025-2030)
Table 47. Recombinant FVIII Price by Application (2019-2024) & (USD/Unit)
Table 48. Global Recombinant FVIII Price Forecast by Application (2025-2030) & (USD/Unit)
Table 49. US & Canada Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 50. US & Canada Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 51. US & Canada Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 52. US & Canada Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 53. US & Canada Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 54. US & Canada Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 55. US & Canada Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 56. US & Canada Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 57. US & Canada Recombinant FVIII Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. US & Canada Recombinant FVIII Revenue by Country (2019-2024) & (US$ Million)
Table 59. US & Canada Recombinant FVIII Revenue by Country (2025-2030) & (US$ Million)
Table 60. US & Canada Recombinant FVIII Sales by Country (2019-2024) & (K Units)
Table 61. US & Canada Recombinant FVIII Sales by Country (2025-2030) & (K Units)
Table 62. Europe Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 63. Europe Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 64. Europe Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 65. Europe Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 66. Europe Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 67. Europe Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 68. Europe Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 69. Europe Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 70. Europe Recombinant FVIII Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe Recombinant FVIII Revenue by Country (2019-2024) & (US$ Million)
Table 72. Europe Recombinant FVIII Revenue by Country (2025-2030) & (US$ Million)
Table 73. Europe Recombinant FVIII Sales by Country (2019-2024) & (K Units)
Table 74. Europe Recombinant FVIII Sales by Country (2025-2030) & (K Units)
Table 75. China Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 76. China Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 77. China Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 78. China Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 79. China Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 80. China Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 81. China Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 82. China Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 83. Asia Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 84. Asia Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 85. Asia Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 86. Asia Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 87. Asia Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 88. Asia Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 89. Asia Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 90. Asia Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 91. Asia Recombinant FVIII Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 92. Asia Recombinant FVIII Revenue by Region (2019-2024) & (US$ Million)
Table 93. Asia Recombinant FVIII Revenue by Region (2025-2030) & (US$ Million)
Table 94. Asia Recombinant FVIII Sales by Region (2019-2024) & (K Units)
Table 95. Asia Recombinant FVIII Sales by Region (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 100. Middle East, Africa and Latin America Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 102. Middle East, Africa and Latin America Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Recombinant FVIII Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 105. Middle East, Africa and Latin America Recombinant FVIII Revenue by Country (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Recombinant FVIII Revenue by Country (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Recombinant FVIII Sales by Country (2019-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Recombinant FVIII Sales by Country (2025-2030) & (K Units)
Table 109. Bayer Company Information
Table 110. Bayer Description and Major Businesses
Table 111. Bayer Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Bayer Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Bayer Recent Developments
Table 114. Baxter Company Information
Table 115. Baxter Description and Major Businesses
Table 116. Baxter Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Baxter Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Baxter Recent Developments
Table 119. Comirnaty Company Information
Table 120. Comirnaty Description and Major Businesses
Table 121. Comirnaty Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Comirnaty Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Comirnaty Recent Developments
Table 124. Novo Nordisk Company Information
Table 125. Novo Nordisk Description and Major Businesses
Table 126. Novo Nordisk Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Novo Nordisk Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Novo Nordisk Recent Developments
Table 129. Green Cross Company Information
Table 130. Green Cross Description and Major Businesses
Table 131. Green Cross Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Green Cross Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Green Cross Recent Developments
Table 134. Sinocelltech Company Information
Table 135. Sinocelltech Description and Major Businesses
Table 136. Sinocelltech Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Sinocelltech Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Sinocelltech Recent Developments
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Recombinant FVIII Distributors List
Table 142. Recombinant FVIII Customers List
Table 143. Recombinant FVIII Market Trends
Table 144. Recombinant FVIII Market Drivers
Table 145. Recombinant FVIII Market Challenges
Table 146. Recombinant FVIII Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant FVIII Product Picture
Figure 2. Global Recombinant FVIII Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Recombinant FVIII Market Share by Type in 2023 & 2030
Figure 4. 250 IU/bottle Product Picture
Figure 5. 500 IU/bottle Product Picture
Figure 6. 1000 IU/bottle Product Picture
Figure 7. 2000 IU/bottle Product Picture
Figure 8. Global Recombinant FVIII Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Recombinant FVIII Market Share by Application in 2023 & 2030
Figure 10. Teenagers
Figure 11. Adults
Figure 12. Recombinant FVIII Report Years Considered
Figure 13. Global Recombinant FVIII Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Recombinant FVIII Revenue 2019-2030 (US$ Million)
Figure 15. Global Recombinant FVIII Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Recombinant FVIII Revenue Market Share by Region (2019-2030)
Figure 17. Global Recombinant FVIII Sales 2019-2030 ((K Units)
Figure 18. Global Recombinant FVIII Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 24. China Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Recombinant FVIII Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Recombinant FVIII in the World: Market Share by Recombinant FVIII Revenue in 2023
Figure 31. Global Recombinant FVIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 33. Global Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 34. Global Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 35. Global Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Recombinant FVIII Revenue Share by Country (2019-2030)
Figure 41. US & Canada Recombinant FVIII Sales Share by Country (2019-2030)
Figure 42. U.S. Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 45. Europe Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 46. Europe Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 47. Europe Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 48. Europe Recombinant FVIII Revenue Share by Country (2019-2030)
Figure 49. Europe Recombinant FVIII Sales Share by Country (2019-2030)
Figure 50. Germany Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 51. France Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 55. China Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 56. China Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 57. China Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 58. China Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 59. Asia Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 60. Asia Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 61. Asia Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 62. Asia Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 63. Asia Recombinant FVIII Revenue Share by Region (2019-2030)
Figure 64. Asia Recombinant FVIII Sales Share by Region (2019-2030)
Figure 65. Japan Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 69. India Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Recombinant FVIII Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Recombinant FVIII Sales Share by Country (2019-2030)
Figure 76. Brazil Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 81. Recombinant FVIII Value Chain
Figure 82. Recombinant FVIII Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Table 1. Global Recombinant FVIII Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of 250 IU/bottle
Table 3. Major Manufacturers of 500 IU/bottle
Table 4. Major Manufacturers of 1000 IU/bottle
Table 5. Major Manufacturers of 2000 IU/bottle
Table 6. Global Recombinant FVIII Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 7. Global Recombinant FVIII Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Recombinant FVIII Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Recombinant FVIII Revenue by Region (2025-2030) & (US$ Million)
Table 10. Global Recombinant FVIII Revenue Market Share by Region (2019-2024)
Table 11. Global Recombinant FVIII Revenue Market Share by Region (2025-2030)
Table 12. Global Recombinant FVIII Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 13. Global Recombinant FVIII Sales by Region (2019-2024) & (K Units)
Table 14. Global Recombinant FVIII Sales by Region (2025-2030) & (K Units)
Table 15. Global Recombinant FVIII Sales Market Share by Region (2019-2024)
Table 16. Global Recombinant FVIII Sales Market Share by Region (2025-2030)
Table 17. Global Recombinant FVIII Sales by Manufacturers (2019-2024) & (K Units)
Table 18. Global Recombinant FVIII Sales Share by Manufacturers (2019-2024)
Table 19. Global Recombinant FVIII Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 20. Global Recombinant FVIII Revenue Share by Manufacturers (2019-2024)
Table 21. Global Key Players of Recombinant FVIII, Industry Ranking, 2022 VS 2023 VS 2024
Table 22. Recombinant FVIII Price by Manufacturers 2019-2024 (USD/Unit)
Table 23. Global Recombinant FVIII Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Recombinant FVIII by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant FVIII as of 2023)
Table 25. Global Key Manufacturers of Recombinant FVIII, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Recombinant FVIII, Product Offered and Application
Table 27. Global Key Manufacturers of Recombinant FVIII, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 30. Global Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 31. Global Recombinant FVIII Sales Share by Type (2019-2024)
Table 32. Global Recombinant FVIII Sales Share by Type (2025-2030)
Table 33. Global Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Recombinant FVIII Revenue Share by Type (2019-2024)
Table 36. Global Recombinant FVIII Revenue Share by Type (2025-2030)
Table 37. Recombinant FVIII Price by Type (2019-2024) & (USD/Unit)
Table 38. Global Recombinant FVIII Price Forecast by Type (2025-2030) & (USD/Unit)
Table 39. Global Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 40. Global Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 41. Global Recombinant FVIII Sales Share by Application (2019-2024)
Table 42. Global Recombinant FVIII Sales Share by Application (2025-2030)
Table 43. Global Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 44. Global Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 45. Global Recombinant FVIII Revenue Share by Application (2019-2024)
Table 46. Global Recombinant FVIII Revenue Share by Application (2025-2030)
Table 47. Recombinant FVIII Price by Application (2019-2024) & (USD/Unit)
Table 48. Global Recombinant FVIII Price Forecast by Application (2025-2030) & (USD/Unit)
Table 49. US & Canada Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 50. US & Canada Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 51. US & Canada Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 52. US & Canada Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 53. US & Canada Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 54. US & Canada Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 55. US & Canada Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 56. US & Canada Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 57. US & Canada Recombinant FVIII Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. US & Canada Recombinant FVIII Revenue by Country (2019-2024) & (US$ Million)
Table 59. US & Canada Recombinant FVIII Revenue by Country (2025-2030) & (US$ Million)
Table 60. US & Canada Recombinant FVIII Sales by Country (2019-2024) & (K Units)
Table 61. US & Canada Recombinant FVIII Sales by Country (2025-2030) & (K Units)
Table 62. Europe Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 63. Europe Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 64. Europe Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 65. Europe Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 66. Europe Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 67. Europe Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 68. Europe Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 69. Europe Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 70. Europe Recombinant FVIII Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 71. Europe Recombinant FVIII Revenue by Country (2019-2024) & (US$ Million)
Table 72. Europe Recombinant FVIII Revenue by Country (2025-2030) & (US$ Million)
Table 73. Europe Recombinant FVIII Sales by Country (2019-2024) & (K Units)
Table 74. Europe Recombinant FVIII Sales by Country (2025-2030) & (K Units)
Table 75. China Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 76. China Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 77. China Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 78. China Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 79. China Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 80. China Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 81. China Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 82. China Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 83. Asia Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 84. Asia Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 85. Asia Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 86. Asia Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 87. Asia Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 88. Asia Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 89. Asia Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 90. Asia Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 91. Asia Recombinant FVIII Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 92. Asia Recombinant FVIII Revenue by Region (2019-2024) & (US$ Million)
Table 93. Asia Recombinant FVIII Revenue by Region (2025-2030) & (US$ Million)
Table 94. Asia Recombinant FVIII Sales by Region (2019-2024) & (K Units)
Table 95. Asia Recombinant FVIII Sales by Region (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Recombinant FVIII Sales by Type (2019-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Recombinant FVIII Sales by Type (2025-2030) & (K Units)
Table 98. Middle East, Africa and Latin America Recombinant FVIII Revenue by Type (2019-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Recombinant FVIII Revenue by Type (2025-2030) & (US$ Million)
Table 100. Middle East, Africa and Latin America Recombinant FVIII Sales by Application (2019-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Recombinant FVIII Sales by Application (2025-2030) & (K Units)
Table 102. Middle East, Africa and Latin America Recombinant FVIII Revenue by Application (2019-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Recombinant FVIII Revenue by Application (2025-2030) & (US$ Million)
Table 104. Middle East, Africa and Latin America Recombinant FVIII Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 105. Middle East, Africa and Latin America Recombinant FVIII Revenue by Country (2019-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Recombinant FVIII Revenue by Country (2025-2030) & (US$ Million)
Table 107. Middle East, Africa and Latin America Recombinant FVIII Sales by Country (2019-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Recombinant FVIII Sales by Country (2025-2030) & (K Units)
Table 109. Bayer Company Information
Table 110. Bayer Description and Major Businesses
Table 111. Bayer Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 112. Bayer Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Bayer Recent Developments
Table 114. Baxter Company Information
Table 115. Baxter Description and Major Businesses
Table 116. Baxter Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 117. Baxter Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Baxter Recent Developments
Table 119. Comirnaty Company Information
Table 120. Comirnaty Description and Major Businesses
Table 121. Comirnaty Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 122. Comirnaty Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Comirnaty Recent Developments
Table 124. Novo Nordisk Company Information
Table 125. Novo Nordisk Description and Major Businesses
Table 126. Novo Nordisk Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 127. Novo Nordisk Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Novo Nordisk Recent Developments
Table 129. Green Cross Company Information
Table 130. Green Cross Description and Major Businesses
Table 131. Green Cross Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 132. Green Cross Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Green Cross Recent Developments
Table 134. Sinocelltech Company Information
Table 135. Sinocelltech Description and Major Businesses
Table 136. Sinocelltech Recombinant FVIII Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 137. Sinocelltech Recombinant FVIII Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Sinocelltech Recent Developments
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. Recombinant FVIII Distributors List
Table 142. Recombinant FVIII Customers List
Table 143. Recombinant FVIII Market Trends
Table 144. Recombinant FVIII Market Drivers
Table 145. Recombinant FVIII Market Challenges
Table 146. Recombinant FVIII Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant FVIII Product Picture
Figure 2. Global Recombinant FVIII Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Recombinant FVIII Market Share by Type in 2023 & 2030
Figure 4. 250 IU/bottle Product Picture
Figure 5. 500 IU/bottle Product Picture
Figure 6. 1000 IU/bottle Product Picture
Figure 7. 2000 IU/bottle Product Picture
Figure 8. Global Recombinant FVIII Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 9. Global Recombinant FVIII Market Share by Application in 2023 & 2030
Figure 10. Teenagers
Figure 11. Adults
Figure 12. Recombinant FVIII Report Years Considered
Figure 13. Global Recombinant FVIII Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Recombinant FVIII Revenue 2019-2030 (US$ Million)
Figure 15. Global Recombinant FVIII Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 16. Global Recombinant FVIII Revenue Market Share by Region (2019-2030)
Figure 17. Global Recombinant FVIII Sales 2019-2030 ((K Units)
Figure 18. Global Recombinant FVIII Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 24. China Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Recombinant FVIII Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Recombinant FVIII Revenue YoY (2019-2030) & (US$ Million)
Figure 29. The Recombinant FVIII Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 30. The Top 5 and 10 Largest Manufacturers of Recombinant FVIII in the World: Market Share by Recombinant FVIII Revenue in 2023
Figure 31. Global Recombinant FVIII Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 32. Global Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 33. Global Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 34. Global Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 35. Global Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 36. US & Canada Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 37. US & Canada Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 38. US & Canada Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 39. US & Canada Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 40. US & Canada Recombinant FVIII Revenue Share by Country (2019-2030)
Figure 41. US & Canada Recombinant FVIII Sales Share by Country (2019-2030)
Figure 42. U.S. Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 43. Canada Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 44. Europe Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 45. Europe Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 46. Europe Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 47. Europe Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 48. Europe Recombinant FVIII Revenue Share by Country (2019-2030)
Figure 49. Europe Recombinant FVIII Sales Share by Country (2019-2030)
Figure 50. Germany Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 51. France Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 52. U.K. Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 53. Italy Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 54. Russia Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 55. China Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 56. China Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 57. China Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 58. China Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 59. Asia Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 60. Asia Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 61. Asia Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 62. Asia Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 63. Asia Recombinant FVIII Revenue Share by Region (2019-2030)
Figure 64. Asia Recombinant FVIII Sales Share by Region (2019-2030)
Figure 65. Japan Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 66. South Korea Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 67. China Taiwan Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 68. Southeast Asia Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 69. India Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Recombinant FVIII Sales Market Share by Type (2019-2030)
Figure 71. Middle East, Africa and Latin America Recombinant FVIII Revenue Market Share by Type (2019-2030)
Figure 72. Middle East, Africa and Latin America Recombinant FVIII Sales Market Share by Application (2019-2030)
Figure 73. Middle East, Africa and Latin America Recombinant FVIII Revenue Market Share by Application (2019-2030)
Figure 74. Middle East, Africa and Latin America Recombinant FVIII Revenue Share by Country (2019-2030)
Figure 75. Middle East, Africa and Latin America Recombinant FVIII Sales Share by Country (2019-2030)
Figure 76. Brazil Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 77. Mexico Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 78. Turkey Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 79. Israel Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 80. GCC Countries Recombinant FVIII Revenue (2019-2030) & (US$ Million)
Figure 81. Recombinant FVIII Value Chain
Figure 82. Recombinant FVIII Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Smart Potentiometric Titrator - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Multifunctional Zeta Potential Analyzer - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Ultrapure Water pH Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Nov 05, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232